Details for 2013751007

Up to date per 02.04.2026

Actions

Title / Product Name

VERFAHREN ZUR KREBSBEHANDLUNG MIT (3-(4-(4-(MORPHOLINOMETHYL)BENZYL)OXY-)1-OXOISOINDOLIN-2-YL-)PIPERIDIN-2,6-DION

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2013751007

EP Publication Number

2882442

E-Number

1399908

Language

PCT Number

US13054055

Publication Date

17.06.2015 A

09.06.2021 B1

Registration Date

09.06.2021

AT Publication Date

15.06.2021

Application Date

08.08.2013

Registration Number

Priorities

09.08.2012

201261681447 P

05.11.2012

201261722727 P

IPC

A61K 31/5377 20060101AFI20201119BHEP

Maximum Duration of Protection

08.08.2033

Owner

Celgene Corporation86 Morris Avenue Summit, NJ 07901US

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

SCHAFER, Peter, H.237 Monroe Avenue Belle Mead, NJ 08502US

GANDHI, Anita37 Stirling Road Bernardsville, NJ 07924US

Information about Fees